Women with depressive symptoms on Day 28 had elevated levels of IL-1β 2 weeks previously (on Day 14) compared to women without symptoms of depression on Day 28.There were no differences in IL-6 levels at any time based on the level of depressive symptoms on Day 28. This evidence concerns the gene IL1B and depressive symptom measurement.